198 related articles for article (PubMed ID: 2014852)
21. Midline involvement as a risk factor for vulvar cancer recurrence.
Stankevica J; Macuks R; Baidekalna I; Donina S
Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
[TBL] [Abstract][Full Text] [Related]
22. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.
Burger MP; Hollema H; Emanuels AG; Krans M; Pras E; Bouma J
Gynecol Oncol; 1995 Jun; 57(3):327-34. PubMed ID: 7774836
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of prognostic indicators in squamous carcinoma of the vulva including nuclear DNA content.
Ballouk F; Ambros RA; Malfetano JH; Ross JS
Mod Pathol; 1993 May; 6(3):371-5. PubMed ID: 8346186
[TBL] [Abstract][Full Text] [Related]
24. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes.
Homesley HD; Bundy BN; Sedlis A; Adcock L
Obstet Gynecol; 1986 Dec; 68(6):733-40. PubMed ID: 3785783
[TBL] [Abstract][Full Text] [Related]
25. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and management of vulvar carcinoma.
Fiorica JV; Lapolla JP; Cavanagh D
Compr Ther; 1988 May; 14(5):24-8. PubMed ID: 3292135
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of the revised international federation of gynecology and obstetrics staging system 2009].
Shen K; Peng P; Wu M
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):721-4. PubMed ID: 21176549
[No Abstract] [Full Text] [Related]
28. Sentinel node biopsy in vulvar cancer: Implications for staging.
Oonk MH; Hollema H; van der Zee AG
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):812-21. PubMed ID: 25962357
[TBL] [Abstract][Full Text] [Related]
29. The number of removed lymph nodes by inguinofemoral lymphadenectomy: impact on recurrence rates in patients with vulva carcinoma.
Diehl A; Volland R; Kirn V; Thangarajah F; Eichler C; Einzmann T; Wirtz M; Ratiu D; Morgenstern B; Fridrich C; Mallmann P; Puppe J
Arch Gynecol Obstet; 2016 Jul; 294(1):131-6. PubMed ID: 26498758
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the vulva: prognostic factors influencing survival.
Hopkins MP; Reid GC; Vettrano I; Morley GW
Gynecol Oncol; 1991 Nov; 43(2):113-7. PubMed ID: 1743551
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of groin lymph node metastases in squamous carcinoma of the vulva.
Hoffman JS; Kumar NB; Morley GW
Obstet Gynecol; 1985 Sep; 66(3):402-5. PubMed ID: 4022498
[TBL] [Abstract][Full Text] [Related]
32. Current treatment of small vulvar cancers.
Hacker NF
Oncology (Williston Park); 1990 Aug; 4(8):21-5; discussion 26, 28, 33. PubMed ID: 2145008
[TBL] [Abstract][Full Text] [Related]
33. Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodes.
Kowalewska M; Radziszewski J; Goryca K; Bujko M; Oczko-Wojciechowska M; Jarzab M; Siedlecki JA; Bidzinski M
BMC Cancer; 2012 Jun; 12():223. PubMed ID: 22673103
[TBL] [Abstract][Full Text] [Related]
34. Unilateral groin and pelvic irradiation for unilaterally node-positive women with vulval carcinoma.
Jackson KS; Fankam EF; Das N; Naik R; Lopes AD; Godfrey KA; Hatem MH; Branson AN; Taylor WT
Int J Gynecol Cancer; 2006; 16(1):283-7. PubMed ID: 16445646
[TBL] [Abstract][Full Text] [Related]
35. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva.
Lataifeh I; Nascimento MC; Nicklin JL; Perrin LC; Crandon AJ; Obermair A
Gynecol Oncol; 2004 Dec; 95(3):701-5. PubMed ID: 15581985
[TBL] [Abstract][Full Text] [Related]
36. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI
Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039
[TBL] [Abstract][Full Text] [Related]
37. Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
Klapdor R; Hillemanns P; Wölber L; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Habermann A; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Meier W; Harter P; Wimberger P; Hanker L; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Jäger M; Mahner S
Ann Surg Oncol; 2017 May; 24(5):1314-1321. PubMed ID: 27896515
[TBL] [Abstract][Full Text] [Related]
38. Separate inguinal incisions in the treatment of carcinoma of the vulva.
Ballon SC; Lamb EJ
Surg Gynecol Obstet; 1975 Jan; 140(1):81-4. PubMed ID: 1209475
[TBL] [Abstract][Full Text] [Related]
39. Groin recurrence following Stage 1A squamous cell carcinoma of the vulva.
Thangavelu A; Andrew A; Buxton EJ
Gynecol Oncol; 2006 Apr; 101(1):172-4. PubMed ID: 16274738
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in carcinoma of the vulva.
Boyce J; Fruchter RG; Kasambilides E; Nicastri AD; Sedlis A; Remy JC
Gynecol Oncol; 1985 Mar; 20(3):364-77. PubMed ID: 3972295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
